Tachydysrhythmias, Valvular disease, Renal failure contribute to chronic heart failure
Hypertension, tachydysrhythmias, valvular disease, cardiomyopathy, and renal failure can contribute to chronic heart failure. Pancreatic disease and pulmonary insufficiency do not contribute to chronic heart failure.
<h3>What is chronic heart failure ?</h3>
A disorder when the heart struggles to circulate blood throughout the body. It might take a while for it to develop. Shortness of breath, difficulty exercising, exhaustion, and swelling of the feet, ankles, and abdomen are among the symptoms.
- Congestive heart failure, often known as heart failure, is a condition where the heart muscle is unable to pump blood as efficiently as it should. Shortness of breath is frequently brought on by this because blood frequently backs up and fluid can accumulate in the lungs.
Learn more about Chronic heart failure here:
brainly.com/question/28121370
#SPJ4
Background- In patients with intracranial artery stenosis, a long-term advantage of dual antiplatelet therapy (DAPT) over single antiplatelet therapy (SAPT) for the prevention of recurrent stroke has not been proven. We studied patients with intracranial arterial stenosis who were enrolled in the Cilostazol Stroke Prevention Study for Antiplatelet Combination trial, a randomized controlled trial in high-risk Japanese patients with ischemic stroke, to compare the efficacy and safety of DAPT with cilostazol and clopidogrel or aspirin to those of SAPT with clopidogrel or aspirin. Techniques and Outcomes In patients with ischemic stroke with symptomatic or asymptomatic intracranial arterial stenosis of at least 50% in a major intracranial artery, we compared the vascular and hemorrhagic events between DAPT and SAPT.
Patients were divided into two groups: 275 were given DAPT, while 272 were given SAPT. In contrast to SAPT, which had a higher risk of serious or life-threatening bleeding, DAPT had a lower risk of ischemic stroke (hazard ratio [HR], 0.47; 95% CI, 0.23-0.95); and a composite of stroke, myocardial infarction, and vascular mortality (HR, 0.48; 95% CI, 0.26-0.91). Conclusions In patients with intracranial artery stenosis following stroke, DAPT using cilostazol was superior than SAPT using clopidogrel or aspirin for the prevention of recurrent stroke and vascular events without raising bleeding risk.
<h3>What is
stroke?</h3>
When anything prevents blood flow to a portion of the brain or when a blood artery in the brain bursts, a stroke, also known as a brain attack, happens. The brain either ages or suffers harm in both scenarios. A stroke may result in permanent brain damage, chronic disability, or even fatality.
To learn more about stroke with the help of given link:
brainly.com/question/26482925
#SPJ4
Icd-10-CM code J96.11. Chronic respiratory failure with hypoxia
Answer Abnormal protein buildup, called amyloidosis